about
Melasma and low-energy Q-switched laser: treatment assessment by means of in vivo confocal microscopy.Random fractional ultrapulsed CO2 resurfacing of photodamaged facial skin: long-term evaluation.Removal of tattoos by q-switched laser: variables influencing outcome and sequelae in a large cohort of treated patients.Nonablative fractional photothermolysis for acne scars: clinical and in vivo microscopic documentation of treatment efficacy.Non-ablative fractionated laser skin resurfacing for the treatment of aged neck skin.Double phase treatment with flashlamp-pumped pulsed-dye laser and long pulsed Nd:YAG laser for resistant port wine stains in adults. Preliminary reports.Activating KIR/HLA complexes in classic Kaposi's SarcomaHHV8 a subtype is associated with rapidly evolving classic Kaposi's sarcoma.Textiles in dermatology: our experience and literature review.Iatrogenic Kaposi's Sarcoma: a Retrospective Cohort Study in an Italian Tertiary Care Centre.Increased Frequency and Vasculogenic Potential of Endothelial Colony-Forming Cells in Patients with Kaposi's Sarcoma.Silver nitrate for Kaposi's sarcoma nodules: A new look at an old treatment.Detection of Polyomavirus in Merkel cell carcinoma by immunohistochemistry: report of three cases.Whole-Genome Sequencing Identifies STAT4 as a Putative Susceptibility Gene in Classic Kaposi Sarcoma.Tocilizumab monotherapy in a patient with rheumatoid arthritis and iatrogenic Kaposi sarcoma.Continuous exposure to Kaposi sarcoma-associated herpesvirus (KSHV) in healthcare workers does not result in KSHV infection.Intrafamiliar transmission of Kaposi's sarcoma-associated herpesvirus and seronegative infection in family members of classic Kaposi's sarcoma patients.Herpes simplex virus infection and pemphigus.Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parameters.Widespread idiopathic pyoderma gangrenosum evolved from ulcerative to vegetative type: a 10-year history with a recent response to infliximab.Toe web intertrigo in Kaposi's sarcoma patients: a microbiological study in a large cohort of patients.Intralesional vincristine as first-line therapy for nodular lesions in classic Kaposi sarcoma: a prospective study in 151 patients.Efficacy of a detergent combined with a moisturiser for the treatment of pruritus associated with xerosis in an elderly population affected by Kaposi's sarcoma.Erosive pustular dermatosis of the scalp induced by ingenol mebutate.Recommended surgery of Kaposi's sarcoma nodules.Treatment of classic Kaposi's sarcoma-associated lymphedema with elastic stockings.Vinorelbine therapy in classic Kaposi's sarcoma: a retrospective study of 20 patients.Onset of Kaposi sarcoma and Merkel cell carcinoma during low-dose steroid therapy for rheumatic polymyalgia.Autoimmune bullous diseases in non-HIV Kaposi's sarcoma: a retrospective study in a large cohort of patients.ERK-Dependent Downregulation of the Atypical Chemokine Receptor D6 Drives Tumor Aggressiveness in Kaposi SarcomaUltrasonographic intraoperative monitoring and follow-up of Kaposi's sarcoma nodules under treatment with intralesional vincristineAuthors’ Reply to Verdelli et al.: There Is No Knowledge Without ExperienceAnaplastic Kaposi's sarcoma: a study of eight patientsDermoscopy of solitary yellow lesions in adultsSuccessful treatment of disseminated superficial actinic porokeratosis with methyl aminolevulinate-photodynamic therapyDermoscopic vascular patterns in nodular "pure" amelanotic melanomaPemphigus herpetiformis associated with prostate cancerPigmented Bowen disease of the palm: an atypical case diagnosed by dermoscopyGranulomatous tattoo reaction induced by intense pulse light treatmentReticular erythematous mucinosis occurring in a brother and sister
P50
Q31144687-055BB6FE-AD94-4E3D-B254-1998DF19F203Q34279450-00ED163A-839C-455E-8F98-BCD484B70417Q34417230-81036985-B018-4E0C-9887-3A398B01AE84Q34436515-1A110D5F-B640-4997-8E08-B53980B6668AQ35192855-B570615E-773F-4666-A9DB-7616DEE48989Q36016915-C31626F6-C4DF-4719-9940-C589F691F3F3Q36048703-B53BA0D4-0AF8-4E28-AD96-CA7FEE7E98D9Q37001427-DB17D4D5-88E0-4740-B9C5-5462CDD41719Q38264737-A98F3FD1-87C6-4155-B10B-1DFF98E33FBFQ38727210-6536E440-76DD-4C1D-B785-DC7F406CF67DQ40296099-43CCD73A-63CB-40C1-9315-D2261CAB6A71Q40610762-F060698E-32B2-49DA-ABFA-A8100D90EBA4Q41019411-38D75FD3-D764-4647-9559-04C54D067AD4Q41607208-23E08116-1C86-41A4-8921-8B14A5814E3AQ42251072-DFE8B72F-940D-438F-B82D-010B157CC5CBQ42278928-3F392767-7F5F-40FD-A66B-675C8C9ACB02Q42685726-3505942C-36E6-44A8-9AF1-2F617B26CBDBQ43263189-F0326A6F-57FC-4B93-B994-E880030D7E8AQ45370762-D9B0D910-EC53-4151-BF96-EFD50F115C4CQ46894702-13A3DEF8-BBB7-4169-BBD1-F0ACD9E5581DQ47576219-7F405A7F-2083-49B2-8DE5-E5FE1858F782Q48392318-D44BD0AB-6DC2-4E82-8B2D-C448B019C27DQ50124495-211876FC-1319-4AFA-AE14-D2F34873837FQ50141877-B3FE5C3F-F855-424D-B6F6-2D83E4BEA3B4Q51109009-E013DA2E-67F5-47F2-971B-5967D6CEB7B6Q51161937-97CA7935-3BCF-4979-AC84-E7776D459A95Q53283707-A7DDD2D1-FA30-4C2F-8171-FF99A48D81BCQ53714715-5D821808-DE1E-4F0A-93D6-019BBDDA88E5Q53939301-A861C853-F34E-42CA-B055-83E8CFE1C2E6Q56942158-3E79A027-EFDC-4DA9-8ADD-DDF7A5B23876Q57473089-50CA7AA4-BCFA-47D7-8ECD-2107FDC6C21DQ60263063-8F06D55F-59D8-418C-BCA3-EAD3F501B0D5Q64051211-78C5752D-C7B7-401F-91A4-BB778DD9C39DQ79659886-5B7BFB1D-D624-4561-BDC7-48276A5D3DC0Q79948383-79C12E57-317F-4910-93F7-96F88C74D6CDQ80167184-D1134694-940C-49C6-891D-A9E90F9AFCBAQ80191259-EC8616A8-3B07-40FB-B509-9E01D6FDB3F3Q82704447-5F5B9454-683E-4E18-9469-2E4E2411092AQ82983145-BE5A0E62-FB23-405F-A508-C79E9AB94CE4Q83364968-C69EE6DB-8B79-47BC-ABF9-7411B3AEC30A
P50
description
researcher ORCID ID = 0000-0002-1636-8315
@en
wetenschapper
@nl
name
Athanasia Tourlaki
@ast
Athanasia Tourlaki
@en
Athanasia Tourlaki
@es
Athanasia Tourlaki
@nl
type
label
Athanasia Tourlaki
@ast
Athanasia Tourlaki
@en
Athanasia Tourlaki
@es
Athanasia Tourlaki
@nl
prefLabel
Athanasia Tourlaki
@ast
Athanasia Tourlaki
@en
Athanasia Tourlaki
@es
Athanasia Tourlaki
@nl
P106
P31
P496
0000-0002-1636-8315